- Home
- GAUZ vs INZY Comparison
GAUZ vs INZY Comparison
Compare GAUZ & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAUZ
- INZY
- Stock Information
- Founded
- GAUZ 2009
- INZY 2015
- Country
- GAUZ Israel
- INZY United States
- Employees
- GAUZ N/A
- INZY N/A
- Industry
- GAUZ Industrial Machinery/Components
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- GAUZ Miscellaneous
- INZY Health Care
- Exchange
- GAUZ Nasdaq
- INZY Nasdaq
- Market Cap
- GAUZ 180.1M
- INZY 256.3M
- IPO Year
- GAUZ 2024
- INZY 2020
- Fundamental
- Price
- GAUZ $8.13
- INZY $4.00
- Analyst Decision
- GAUZ Strong Buy
- INZY Buy
- Analyst Count
- GAUZ 4
- INZY 9
- Target Price
- GAUZ $15.50
- INZY $15.22
- AVG Volume (30 Days)
- GAUZ 25.4K
- INZY 1.1M
- Earning Date
- GAUZ 08-07-2025
- INZY 08-05-2025
- Dividend Yield
- GAUZ N/A
- INZY N/A
- EPS Growth
- GAUZ N/A
- INZY N/A
- EPS
- GAUZ N/A
- INZY N/A
- Revenue
- GAUZ $101,165,000.00
- INZY N/A
- Revenue This Year
- GAUZ $28.49
- INZY N/A
- Revenue Next Year
- GAUZ $47.77
- INZY N/A
- P/E Ratio
- GAUZ N/A
- INZY N/A
- Revenue Growth
- GAUZ 18.63
- INZY N/A
- 52 Week Low
- GAUZ $6.78
- INZY $0.72
- 52 Week High
- GAUZ $13.00
- INZY $6.24
- Technical
- Relative Strength Index (RSI)
- GAUZ N/A
- INZY 82.68
- Support Level
- GAUZ N/A
- INZY $3.94
- Resistance Level
- GAUZ N/A
- INZY $3.97
- Average True Range (ATR)
- GAUZ 0.00
- INZY 0.01
- MACD
- GAUZ 0.00
- INZY -0.09
- Stochastic Oscillator
- GAUZ 0.00
- INZY 100.00
About GAUZ Gauzy Ltd. Ordinary Shares
Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.